Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage

Neurocritical Care

Volumn 13, Issue 3, 2010, Pages 321-325

  Rizos, Timolaos ^a   Jenetzky, Ekkehart ^b   Herweh, Christian ^a   Unterberg, Andreas ^a   Hacke, Werner ^a   Veltkamp, Roland ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Oral anticoagulation; Reversal treatment; Subdural hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; PHENPROCOUMON; PROTHROMBIN COMPLEX;

AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; EMERGENCY TREATMENT; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL INSTRUMENTATION; PATIENT CARE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBDURAL HEMATOMA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; CRITICAL CARE; DRUG MONITORING; FEMALE; HEMATOMA, SUBDURAL, ACUTE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649700636     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9443-1     Document Type: Article

References (24)

1. JP Hanley 2004 Warfarin reversal J Clin Pathol 57 1132 1139 1:CAS:528:DC%2BD2cXhtVKisb3O 10.1136/jcp.2003.008904 15509671 (Pubitemid 39486516)
2. S De Wilde IM Carey C Emmas N Richards DG Cook 2006 Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care Heart 92 1064 1070 10.1136/hrt.2005.069492 (Pubitemid 44131331)
3. SJ Connolly MD Ezekowitz, et al. 2009 Dabigatran versus Warfarin in patients with atrial fibrillation NEJM 361 1139 1151 1:CAS:528: DC%2BD1MXhtFOjsLnN 10.1056/NEJMoa0905561 19717844
4. EM Bershad S Farhadi MF Suri ES Feen OH Hernandez WR Selman JI Suarez 2008 Coagulopathy and inhospital deaths in patients with acute subdural hematoma J Neurosurg 109 664 669 10.3171/JNS/2008/109/10/0664 18826353
5. RG Hart BS Boop DC Anderson 1995 Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 1471 1477 1:STN:280: DyaK2MzlslyntA%3D%3D 7631356
6. B Depreitere F Van Calenbergh J van Loon 2003 A clinical comparison of non-traumatic acute subdural haematomas either related to coagulopathy or of arterial origin without coagulopathy Acta Neurochir 145 541 546 1:STN:280:DC%2BD3sznsVCgsQ%3D%3D 10.1007/s00701-003-0020-7 (Pubitemid 37093955)
7. MJ Schneck M Maheswaran S Leurgans 2004 Predictors of outcomes after nontraumatic subdural hematoma J Stroke Cerebrovasc Dis 13 192 195 10.1016/j.jstrokecerebrovasdis.2004.08.003 17903975 (Pubitemid 39421627)
8. J Ansell J Hirsh E Hylek A Jacobson M Crowther G Palareti 2008 Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 160S 198S 1:CAS:528:DC%2BD1cXptVKiu7o%3D 10.1378/chest.08-0670 18574265 (Pubitemid 351892967)
9. T Rizos E Jenetzky C Herweh A Hug W Hacke T Steiner R Veltkamp 2010 Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage Ann Neurol 67 788 793 20517940
10. P Junagade R Grace P Gover 2007 Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy Hematology 12 439 440 1:CAS:528:DC%2BD2sXhtVOitLrK 10.1080/10245330701448529 17852462 (Pubitemid 47487854)
11. T Steiner M Kaste M Katse M Forsting D Mendelow H Kwiecinski I Szikora S Juvela A Marchel R Chapot C Cognard A Unterberg W Hacke 2006 Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee Cerebrovasc Dis 22 294 316 10.1159/000094831 16926557 (Pubitemid 44338094)
12. J Broderick S Connolly E Feldmann D Hanley C Kase D Krieger M Mayberg L Morgenstern CS Ogilvy P Vespa M Zuccarello 2007 Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group Stroke 38 2001 2023 10.1161/STROKEAHA.107.183689 17478736 (Pubitemid 46850654)
13. Anon 1998 Guidelines on oral anticoagulation: third edition Br J Haematol 101 374 387 10.1046/j.1365-2141.1998.00715.x (Pubitemid 28261130)
14. J Ansell J Hirsh J Dalen H Bussey D Anderson L Poller A Jacobson D Deykin D Matchar 2001 Managing oral anticoagulant therapy Chest 119 22S 38S 1:STN:280:DC%2BD3M7ptlarsw%3D%3D 10.1378/chest.119.1-suppl.22S 11157641
15. RI Baker PB Coughlin AS Gallus PL Harper HH Salem EM Wood 2004 Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thromb Haemost Med J 181 492 497
16. M Kohler P Hellstern E Lechler P Uberfuhr G Muller-Berghaus 1998 Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates Thromb Haemost 80 399 402 1:STN:280:DyaK1cvjtVCitQ%3D%3D 9759617 (Pubitemid 28438732)
17. T Rizos C Herweh E Jenetzky C Lichy PA Ringleb W Hacke R Veltkamp 2009 Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants Stroke 40 3547 3551 1:CAS:528:DC%2BD1MXhtlWgu7bJ 10.1161/STROKEAHA.109.562769 19696414
18. TL Green A Mansoor N Newcommon C Stephenson E Stewart MD Hill 2008 Reliability of point-of-care testing of INR in acute stroke Can J Neurol Sci 35 348 351 18714804
19. T Steiner J Rosand M Diringer 2006 Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions Stroke 37 256 262 1:CAS:528:DC%2BD2MXhtlagsb%2FP 10.1161/01.STR.0000196989. 09900.f8 16339459 (Pubitemid 43732088)
20. MI Aguilar RG Hart CS Kase WD Freeman BJ Hoeben RC Garcia JE Ansell SA Mayer B Norrving J Rosand T Steiner EF Wijdicks T Yamaguchi M Yasaka 2007 Treatment of Warfarin-associated intracerebral hemorrhage: literature review and expert opinion Mayo Clin Proc 82 82 92 1:CAS:528:DC%2BD2sXhtVCmsL4%3D 10.4065/82.1.82 17285789
21. I Pabinger B Brenner U Kalina S Knaub A Nagy H Ostermann 2008 Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial J Thromb Haemost 6 622 631 1:CAS:528:DC%2BD1cXltFCqs78%3D 10.1111/j.1538-7836.2008.02904.x 18208533 (Pubitemid 351404929)
22. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 307 310 1:STN:280:DyaL287hslWqsQ%3D%3D 2868172
23. SB Lee EM Manno KF Layton EF Wijdicks 2006 Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP Neurology 67 1272 1274 1:CAS:528:DC%2BD28XhtFyqtb7N 10.1212/01.wnl.0000238104. 75563.2f 17030765 (Pubitemid 44566354)
24. DL Brody V Aiyagari AM Shackleford MN Diringer 2005 Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage Neurocrit Care 2 263 267 10.1385/NCC:2:3:263 16159073 (Pubitemid 41112397)